Umm, are you really trying to say that the company received 30+ asks to sign NDAs/CDAs to wander into the data room, but for some reason the company (PAR) then turned around after the signing of those documents and didn't let them in?
"Hey we have all this interest, but bugger it we aint letting you in".
I mean anything is possible, but jeez @Dungiven you have more than interrogated that, you have twisted and pulled and shaken and stirred the heck out of it to hear what you want to hear....
Sorry but you've gone out on a ledge to far for me here.
- Forums
- ASX - By Stock
- PAR
- The Ghosh Study - PART 1
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
4.84%
!
29.5¢

The Ghosh Study - PART 1, page-38
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.5¢ |
Change
-0.015(4.84%) |
Mkt cap ! $114.8M |
Open | High | Low | Value | Volume |
31.0¢ | 31.0¢ | 29.0¢ | $67.50K | 220.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 35330 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 44652 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 35330 | 0.290 |
7 | 110688 | 0.285 |
21 | 368416 | 0.280 |
7 | 73263 | 0.275 |
6 | 106424 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 44652 | 7 |
0.305 | 2746 | 1 |
0.310 | 57505 | 3 |
0.315 | 59233 | 3 |
0.320 | 108906 | 8 |
Last trade - 13.04pm 18/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online